Acura Pharmaceuticals Inc - Company & Market Research Reports

Acura Pharmaceuticals is a pharmaceutical company focused on the development and commercialization of deterrents to medication abuse and misuse. It offers Oxaydo tablets, a Schedule II narcotic indicated for the management of acute and chronic moderate to pain and Nexafed products, which are pseudoephedrine and acetaminophen tablets that are used as nasal decongestants. The company was founded in 1935 and is based in Palatine, Illinois.


Prescription Pain Drugs - Including Opioid, Anticonvulsant, Injectable/ Inhaled, Topical/ Transdermal, Medical Marijuana - 2015-2020 Analysis and Forecasts - Product Thumbnail Image

Prescription Pain Drugs - Including Opioid, Anticonvulsant, Injectable/ Inhaled, Topical/ Transdermal, Medical Marijuana - 2015-2020 Analysis and Forecasts

  • Report
  • 283 Pages
From
Pain Management- New Discoveries And Treatment Options In Abuse Deterrent Era - Product Thumbnail Image

Pain Management- New Discoveries And Treatment Options In Abuse Deterrent Era

  • Report
  • 135 Pages
From
Pain Management - Medical Devices Pipeline Assessment, 2017 - Product Thumbnail Image

Pain Management - Medical Devices Pipeline Assessment, 2017

  • Report
  • 295 Pages
From
Opioid Receptor Agonist -Pipeline Insight, 2018 - Product Thumbnail Image

Opioid Receptor Agonist -Pipeline Insight, 2018

  • Drug Pipelines
  • 90 Pages
From
Q3 2016 Earnings Call - Acura Pharmaceuticals, Inc., - Earnings Transcript - Product Thumbnail Image

Q3 2016 Earnings Call - Acura Pharmaceuticals, Inc., - Earnings Transcript

  • Earnings Transcript
Q2 2016 Earnings Call - Acura Pharmaceuticals, Inc., - Earnings Transcript - Product Thumbnail Image

Q2 2016 Earnings Call - Acura Pharmaceuticals, Inc., - Earnings Transcript

  • Earnings Transcript
AP-LTX-400 Cohort 2 Study Results Call - Acura Pharmaceuticals, Inc., - Earnings Transcript - Product Thumbnail Image

AP-LTX-400 Cohort 2 Study Results Call - Acura Pharmaceuticals, Inc., - Earnings Transcript

  • Earnings Transcript
Acura Pharmaceuticals Inc (ACUR:PINX): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry - Product Thumbnail Image

Acura Pharmaceuticals Inc (ACUR:PINX): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry

  • Company Profile
  • 84 Pages
From
Acura Pharmaceuticals Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis - Product Thumbnail Image

Acura Pharmaceuticals Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

  • Company Profile
  • 50 Pages
From
Acura Pharmaceuticals Inc (ACUR) - Financial and Strategic SWOT Analysis Review - Product Thumbnail Image

Acura Pharmaceuticals Inc (ACUR) - Financial and Strategic SWOT Analysis Review

  • SWOT Analysis
  • 42 Pages
From
Acura Pharmaceuticals Inc Company Profile - Business Operations, Strategies, SWOT Analysis and Financial Report - Product Thumbnail Image

Acura Pharmaceuticals Inc Company Profile - Business Operations, Strategies, SWOT Analysis and Financial Report

  • Financial Report
  • 35 Pages
From
Acura Pharmaceuticals, Inc. Company Profile - Business Strategies, Outlook Statement, Business Description, Products and Services, Competitors, Employees, Updates, SWOT and Financials - Product Thumbnail Image

Acura Pharmaceuticals, Inc. Company Profile - Business Strategies, Outlook Statement, Business Description, Products and Services, Competitors, Employees, Updates, SWOT and Financials

  • Company Profile
  • 30 Pages
From
Acura Pharmaceuticals, Inc. - Product Thumbnail Image

Acura Pharmaceuticals, Inc.

  • Company Profile
  • 69 Pages
Acura Pharmaceuticals Inc Strategic Analysis Review - Acura Pharmaceuticals Inc SWOT, Outlook, Operations and Financial Profile - Product Thumbnail Image

Acura Pharmaceuticals Inc Strategic Analysis Review - Acura Pharmaceuticals Inc SWOT, Outlook, Operations and Financial Profile

  • Company Profile
  • 30 Pages
From
Q2 2017 Earnings Call - Acura Pharmaceuticals, Inc., - Earnings Transcript - Product Thumbnail Image

Q2 2017 Earnings Call - Acura Pharmaceuticals, Inc., - Earnings Transcript

  • Earnings Transcript
Q4 2016 Earnings Call - Acura Pharmaceuticals, Inc., - Earnings Transcript - Product Thumbnail Image

Q4 2016 Earnings Call - Acura Pharmaceuticals, Inc., - Earnings Transcript

  • Earnings Transcript
AP-LTX-400 Study Results Call - Acura Pharmaceuticals, Inc., - Earnings Transcript - Product Thumbnail Image

AP-LTX-400 Study Results Call - Acura Pharmaceuticals, Inc., - Earnings Transcript

  • Earnings Transcript
Q3 2015 Earnings Call - Acura Pharmaceuticals, Inc., - Earnings Transcript - Product Thumbnail Image

Q3 2015 Earnings Call - Acura Pharmaceuticals, Inc., - Earnings Transcript

  • Earnings Transcript
Q1 2015 Earnings Call - Acura Pharmaceuticals, Inc., - Earnings Transcript - Product Thumbnail Image

Q1 2015 Earnings Call - Acura Pharmaceuticals, Inc., - Earnings Transcript

  • Earnings Transcript
Q3 2014 Earnings Call - Acura Pharmaceuticals, Inc., - Earnings Transcript - Product Thumbnail Image

Q3 2014 Earnings Call - Acura Pharmaceuticals, Inc., - Earnings Transcript

  • Earnings Transcript
  • 20 Results (Page 1 of 1)
Loading Indicator
adroll